Literature DB >> 12515789

Accutane (isotretinoin) and psychiatric adverse effects.

Eric Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12515789      PMCID: PMC139322     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Common problems in the management of hypertriglyceridemia.

Authors:  Michelle A Fung; Jiri J Frohlich
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

Review 2.  Medical genetics: 1. Clinical teratology in the age of genomics.

Authors:  Janine E Polifka; J M Friedman
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

3.  Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis.

Authors:  M A Gupta; A K Gupta
Journal:  Br J Dermatol       Date:  1998-11       Impact factor: 9.302

4.  Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.

Authors:  Diane K Wysowski; Joslyn Swann; Amarilys Vega
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

5.  Treatment of acne vulgaris and prevention of acne scarring: canadian consensus guidelines.

Authors:  W S Madden; I D Landells; Y Poulin; G E Searles; K C Smith; J K Tan; J Toole; C M Zip; H Degreef
Journal:  J Cutan Med Surg       Date:  2000-06       Impact factor: 2.092

6.  An analysis of reports of depression and suicide in patients treated with isotretinoin.

Authors:  D K Wysowski; M Pitts; J Beitz
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

7.  Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.

Authors:  S S Jick; H M Kremers; C Vasilakis-Scaramozza
Journal:  Arch Dermatol       Date:  2000-10

Review 8.  Uses and complications of isotretinoin therapy.

Authors:  C N Ellis; K J Krach
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

9.  Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin.

Authors:  D R Rubinow; G L Peck; K M Squillace; G G Gantt
Journal:  J Am Acad Dermatol       Date:  1987-07       Impact factor: 11.527

  9 in total
  6 in total

Review 1.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

Review 2.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 3.  The neurobiology of retinoic acid in affective disorders.

Authors:  J Douglas Bremner; Peter McCaffery
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-10       Impact factor: 5.067

4.  Presumed isotretinoin-induced, concomitant autoimmune thyroid disease and ocular myasthenia gravis: a case report.

Authors:  Huseyin Gursoy; Idil Cakmak; Nilgun Yildirim; Hikmet Basmak
Journal:  Case Rep Dermatol       Date:  2012-09-16

Review 5.  Psychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne Vulgaris.

Authors:  Alessandra Suuberg
Journal:  Curr Ther Res Clin Exp       Date:  2019-02-10

6.  Isotretinoin and psychopathology: a review.

Authors:  Vassilis P Kontaxakis; Demetris Skourides; Panayotis Ferentinos; Beata J Havaki-Kontaxaki; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-01-20       Impact factor: 3.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.